Understanding valvular heart disease in patients with systemic autoimmune diseases

Area of Science:

• Cardiology
• Rheumatology
• Immunology

Background:

• Systemic autoimmune diseases are complex conditions affecting multiple organ systems.
• Valvular heart disease is a recognized, yet often underappreciated, manifestation of certain autoimmune disorders.
• Understanding these associations is crucial for comprehensive patient management.

Purpose of the Study:

• To review and delineate the specific valvular heart disorders associated with various systemic autoimmune diseases.
• To highlight the spectrum of cardiac involvement in rheumatologic and immunologic conditions.
• To provide a consolidated resource for clinicians managing patients with autoimmune diseases and potential cardiac complications.

Main Methods:

• Literature review of studies investigating valvular heart disorders in systemic autoimmune diseases.
• Synthesis of findings related to rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid antibody syndrome, seronegative spondyloarthropathies, systemic vasculitides, and scleroderma.
• Categorization of valvular manifestations based on the associated autoimmune condition.

Main Results:

• Rheumatoid arthritis is associated with specific valvular lesions, including rheumatoid nodules and fibrosis.
• Systemic lupus erythematosus can lead to Libman-Sacks endocarditis and valvular thickening.
• Antiphospholipid antibody syndrome presents with a risk of thrombotic valvular vegetations and regurgitation.
• Seronegative spondyloarthropathies, vasculitides, and scleroderma also exhibit distinct patterns of valvular involvement.

Conclusions:

• A clear association exists between specific systemic autoimmune diseases and distinct valvular heart disorders.
• Recognition of these associations aids in early diagnosis and targeted treatment of cardiac complications.
• Further research into the pathomechanisms and optimal management strategies for these valvular conditions is warranted.